SCHEMBL18274749

SCHEMBL18274749

CN(C)CCOc1cccc(-c2ccc(Cl)cc2)c1CN1CCN(c2ccc(Oc3ccccc3C(=O)NS(=O)(=O)c3ccc(NCC4CCOCC4)c([N+](=O)[O-])c3)cc2)CC1

nearest known ligand 0.91

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ BCL2 P10415 10/20 0.81

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1956587 0.95 BCL2 (0.86) BCL2
SCHEMBL1955522 0.90 BCL2 (0.79) BCL2
SCHEMBL1958654 0.90 BCL2 (1.00) BCL2
SCHEMBL1956538 0.89 BCL2 (0.78) BCL2
SCHEMBL19424712 0.89 BCL2 (0.75) BCL2
SCHEMBL1956920 0.87 BCL2 (1.00) BCL2
SCHEMBL1956414 0.87 BCL2 (0.89) BCL2
SCHEMBL1959457 0.86 BCL2 (0.72) BCL2
SCHEMBL1957907 0.85 BCL2 (1.00) BCL2
SCHEMBL1957407 0.85 BCL2 (0.84) BCL2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3101019-A1 SULFONAMIDE DERIVATIVES AS BCL-2-SELECTIVE APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE DISEASES AbbVie Inc. (US) 2016-12-07 — — EP claimed
Send feedback